Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 1
1999 1
2000 1
2001 1
2003 1
2004 2
2005 3
2006 1
2007 1
2009 3
2010 2
2012 4
2013 1
2014 1
2015 3
2017 2
2018 2
2019 2
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

33 results
Results by year
Filters applied: . Clear all
Page 1
MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit.
Løkkegaard S, Elias D, Alves CL, Bennetzen MV, Lænkholm AV, Bak M, Gjerstorff MF, Johansen LE, Vever H, Bjerre C, Kirkegaard T, Nordenskjöld B, Fornander T, Stål O, Lindström LS, Esserman LJ, Lykkesfeldt AE, Andersen JS, Leth-Larsen R, Ditzel HJ. Løkkegaard S, et al. Among authors: leth larsen r. NPJ Breast Cancer. 2021 Jan 4;7(1):2. doi: 10.1038/s41523-020-00210-8. NPJ Breast Cancer. 2021. PMID: 33398005 Free PMC article.
Surfactant protein D in the female genital tract.
Leth-Larsen R, Floridon C, Nielsen O, Holmskov U. Leth-Larsen R, et al. Mol Hum Reprod. 2004 Mar;10(3):149-54. doi: 10.1093/molehr/gah022. Epub 2004 Jan 29. Mol Hum Reprod. 2004. PMID: 14981140
33 results